Andrey Voronkov

PhD. Graduated from Lomonosov Moscow State University. From 2009 to 2014, he worked as a postdoctoral fellow at the University of Oslo and was involved in the development of anti-cancer drugs (through the impact on the signaling pathways of cancer stem cells). From 2015 to 2017, he worked as Science Director at IVAO. After that, he participated as a co-founder and expert in several well-known blockchain startups.

Owner and founder of the consulting companies Voronkov Ventures LLC and Digital BioPharm ltd. Since 2019, he has been managing blockchain organizations within the UniDao platform. He is also involved in scientific work at Moscow State University in the Department of Medicinal Chemistry.

Fields of interest: high-performance computing in bioinformatics and chemoinformatics, blockchain and venture capital investments.